Biodexa Pharmaceuticals Plc
BDRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001643918
No open-market purchases or sales by Biodexa Pharmaceuticals Plc insiders were filed in the last 90 days; 8 institutions reported holding it in 13F filings for Q2 2026, worth $48.1K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Biodexa Pharmaceuticals Plc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 8 | 8 | 0 |
| SharesConverted for a 1-for-5 split | 73.8K | 16.6K | −57.3K (−77.6%) |
| Value | $228.1K | $48.1K | −$180.0K (−78.9%) |
New holders (1)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Allied Private Wealth LLC | 489 | $1.27K | 0.00% |
Sold out (1)
Institutions that held Biodexa Pharmaceuticals Plc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Sabby Management, LLC | 257,472 | $159.1K |